Incept LLC
Cultivating Medical Innovation
News
Boston Scientific Announces Agreement To Acquire Augmenix, Inc.
Acquisition expands portfolio of men's health in-office procedures with adjunctive therapy for prostate cancer patients Sep 6, … [Read More...]
Boston Scientific Announces Agreement to Acquire Apama Medical
MARLBOROUGH, Mass., Oct. 2, 2017 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced a definitive agreement to acquire Apama … [Read More...]
Boston Scientific to acquire Apama Medical in deal worth up to $300m
Boston Scientific (NYSE:BSX) said today it inked a deal worth up to $300 million to acquire Apama Medical and its radiofrequency balloon catheter … [Read More...]
FDA clears Claret Medical’s Sentinel TAVR stroke protection device for U.S. market
The FDA has cleared the use of Claret Medical’s Sentinel cerebral protection system in the U.S., making the device the first and only of its kind on … [Read More...]
Claret Medical Receives FDA Clearance to Market Sentinel Cerebral Protection System in the U.S.
SANTA ROSA, Calif.--(BUSINESS WIRE)--Claret Medical® today announced that it has received regulatory clearance from the U.S. Food and Drug … [Read More...]
Phase 3 Trial Data Show Use of SpaceOAR® Hydrogel Helps Maintain Erectile Function Following Prostate Cancer Radiation Treatment
Lower penile bulb radiation dose may be associated with ability to maintain sexual function and potency BEDFORD, Mass.--(BUSINESS WIRE)--Augmenix, … [Read More...]
FDA Panel Reviews Claret Medical’s Sentinel Cerebral Protection System for TAVR
February 27, 2017—Claret Medical Inc. announced that in an open public hearing of the US Food and Drug Administration's Circulatory System Devices … [Read More...]
FDA Panel Says Yes to Sentinel Approval
Safety, not benefit, carries the day by Nicole Lou Reporter, MedPage Today/CRTonline.orgFebruary 23, 2017 Despite the cloud of questions … [Read More...]